🔄
Covid-19 and systemic therapies for psoriasis: What to do?? Skip to content

Cart

Your cart is empty

Article: Covid-19 and systemic therapies for psoriasis: What to do??

Covid-19 and systemic therapies for psoriasis: What to do??

Covid-19 and systemic therapies for psoriasis: What to do??

Having Gluten Allergy and any other autoimmune disease such as psoriasis is not easy in these times…

There is no guidance at this time from the Centers of Disease Control (CDC) or the Department of Public Health on how psoriasis patients should respond to the Coronavirus (Covid-19) epidemic, nor are there good studies in the literature for physicians to use as a basis for recommendations. This is what Dr. Jeffrey Sobell, an internationally renowned psoriasis expert, recommends:

For psoriasis patients on biologics (Enbrel, Humira, Remicade, Cimzia, Stelara, Cosentyx, Taltz, Siliq, Tremfya, Ilumya, Skyrizi)
For patients who have been healthy on their biologic up to now with no obvious increase in infection rate, continuing therapy LIKELY WILL NOT increase their risk of contracting the virus. Furthermore, if an infection should occur, it is NOT LIKELY that their ability to fight the infection will be affected. But, of course, as with any significant infection, patients should hold future doses until they fully recover.

With that being said, if psoriasis patients are still concerned and would rather hold their biologic medication for now, that is certainly a reasonable option. But keep in mind the following two issues:

1) The psoriasis will recur. Depending on the specific biologic, half the psoriasis returns on average in 3 to 6 months.
2) Restarting the biologic after a long break may or may not work as well as their previous experience to control their psoriasis.
For psoriasis patients on oral prescriptions
1) For patients on Cyclosporine and Methotrexate, Dr. Sobell advises to reduce the dose to the lowest possible that still adequately controls their symptoms. For patients on Otezla, as it is not associated with a high risk of infection, it is reasonable to continue at the current dose. But, should a significant infection occur while under any of these three treatments, Dr. Sobell would hold future doses of all three of these medications until the infection has completely resolved.
2) For patients on Acitretin, this medication does not impair the immune system so it is acceptable to continue.
For all patients
Our best defense against infection is proper hand hygiene and avoidance of close contact with people showing signs of respiratory illness.

If you have specific concerns about your psoriasis therapy and Covid-19, contact your dermatologist or physician.

In the meantime stay safe and healthy!

Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Read more

What the Research Says About 10 Controversial Cosmetics Ingredients
About EpiLynx

What the Research Says About 10 Controversial Cosmetics Ingredients

EpiLynx does not use phthalates or parabens or any of the below mentioned ingredients…. So why is FDA still silent about all of the below???? Breaking down the complex safety science of beauty. By ...

Read more
COVID-19

Lets embrace our humanity in this horrible pandemic of covid -19

When SovietUnion fell in 1991 we moved to the Netherlands because my Dad gave up everything in Russia (his position, home, status, money) to move to the University of Groningen while my beloved gra...

Read more